HomeCompareKYCH vs JNJ

KYCH vs JNJ: Dividend Comparison 2026

KYCH yields 48.78% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KYCH wins by $349.9K in total portfolio value
10 years
KYCH
KYCH
● Live price
48.78%
Share price
$4.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$369.9K
Annual income
$73,498.95
Full KYCH calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — KYCH vs JNJ

📍 KYCH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKYCHJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KYCH + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KYCH pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KYCH
Annual income on $10K today (after 15% tax)
$4,146.34/yr
After 10yr DRIP, annual income (after tax)
$62,474.11/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, KYCH beats the other by $61,770.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KYCH + JNJ for your $10,000?

KYCH: 50%JNJ: 50%
100% JNJ50/50100% KYCH
Portfolio after 10yr
$195.0K
Annual income
$37,163.37/yr
Blended yield
19.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

KYCH
No analyst data
Altman Z
-7.0
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KYCH buys
0
JNJ buys
0
No recent congressional trades found for KYCH or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKYCHJNJ
Forward yield48.78%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$369.9K$20.0K
Annual income after 10y$73,498.95$827.78
Total dividends collected$293.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: KYCH vs JNJ ($10,000, DRIP)

YearKYCH PortfolioKYCH Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$15,578$4,878.05$10,676$355.77+$4.9KKYCH
2$23,770$7,101.91$11,407$389.39+$12.4KKYCH
3$35,562$10,127.81$12,198$426.53+$23.4KKYCH
4$52,212$14,160.64$13,056$467.62+$39.2KKYCH
5$75,297$19,430.44$13,987$513.12+$61.3KKYCH
6$106,757$26,188.32$14,998$563.56+$91.8KKYCH
7$148,930$34,700.70$16,098$619.52+$132.8KKYCH
8$204,597$45,242.09$17,295$681.69+$187.3KKYCH
9$277,006$58,086.63$18,599$750.82+$258.4KKYCH
10$369,895$73,498.95$20,022$827.78+$349.9KKYCH

KYCH vs JNJ: Complete Analysis 2026

KYCHStock

Keyarch Acquisition Corporation does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on disruptive technology and innovative services companies worldwide. The company was incorporated in 2021 and is based in New York, New York.

Full KYCH Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this KYCH vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KYCH vs SCHDKYCH vs JEPIKYCH vs OKYCH vs KOKYCH vs MAINKYCH vs ABBVKYCH vs MRKKYCH vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.